FRONT ONCOL 2021 10.3389/fonc.2021.691277

Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea

Lee¹, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

MOLECULES 2021 10.3390/molecules26123644

Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S

ONCOL REP 2021 10.3892/or.2021.8040

Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S

J CELL SCI 2021 10.1242/jcs.256503

YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ER alpha

Kim¹, H; Son, S; Ko, Y; Lee, JE; Kim, S; Shin, I

FRONT ONCOL 2021 10.3389/fonc.2021.596364

Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry

Kim¹, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH

ONCOL LETT 2021 10.3892/ol.2021.12555

Inhibition of platelet-derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor alpha positive breast cancer

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Lee, JE

BMC SURG 2021 10.1186/s12893-021-01129-y

The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW

EUR J PHARMACOL 2021 10.1016/j.ejphar.2021.173868

Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Lee, JE

EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023

Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer

Woo¹, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

J BREAST CANC 2021 10.4048/jbc.2021.24.e4

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

Min¹, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ

FRONT ONCOL 2021 10.3389/fonc.2021.588728

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer

Kwon¹, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE

BMC CANCER 2021 10.1186/s12885-020-07729-w

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?

Jung¹, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE

JAMA SURG 2020 10.1001/jamasurg.2020.4124

Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence

Lee¹, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI

J BREAST CANC 2020 10.4048/jbc.2020.23.e61

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation

Jung¹, SM; Ryu, JM; Park, HS; Park, JS; Kang, E; Lee, S; Lee, HB; Youn, HJ; Yoo, TK; Kim, J; Lee, JE; Han, SA; Kim, D; Kim, SW

NAT COMMUN 2020 10.1038/s41467-020-19933-0

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

Park¹, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z

SCI REP-UK 2020 10.1038/s41598-020-77324-3

Application of an open-chamber multi-channel microfluidic device to test chemotherapy drugs

Moon¹, HS; Yoo, CE; Kim, S; Lee, JE; Park, WY

BREAST CANCER RES TR 2020 10.1007/s10549-020-05875-0

Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer

Sim¹, EJ; Ko, KP; Ahn, C; Park, SM; Surh, YJ; An, S; Kim, SW; Lee, MH; Lee, JW; Lee, JE; Kim, KS; Yom, CK; Kim, HA; Park, SK

ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Jung¹, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE

CYTOKINE 2020 10.1016/j.cyto.2020.155213

WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE

INT J MOL SCI 2020 10.3390/ijms21228697

ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer

Schabort¹, JJ; Nam, AR; Lee, KH; Kim, SW; Lee, JE; Cho, JY

ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444

Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer

Kim¹, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY

MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108

Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

Park¹, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH

NUTRIENTS 2020 10.3390/nu12092831

Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients

Kim¹, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY

J CLIN MED 2020 10.3390/jcm9092846

Impact of Serum Lipid on Breast Cancer Recurrence

Jung¹, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK

BRIT J SURG 2020 10.1002/bjs.11572

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

Kim¹, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

CANCER RES TREAT 2020 10.4143/crt.2019.351

Clinicopathological Features of Patients with the BRCA1 c.5339T > C (p.Leu1780Pro) Variant

Park¹, HS; Ryu, JM; Park, JS; Im, SA; Jung, SY; Kim, EK; Park, WC; Min, JW; Lee, J; You, JY; Lee, JE; Kim, SW

ANN SURG TREAT RES 2020 10.4174/astr.2020.98.5.215

Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study

Kim¹, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ

BRIT J SURG 2020 10.1002/bjs.11572

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

J CLIN MED 2020 10.3390/jcm9041192

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence

Ryu¹, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147

Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

Ryu¹, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

J BREAST CANC 2019 10.4048/jbc.2019.22.e48

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm

Alsharif¹, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

JAMA Oncol 2019 10.1001/jamaoncol.2019.0620

Insights Into Breast Cancer in the East vs the West: A Review

Yap¹, YS; Lu, YS; Tamura, K; Lee, JE; Ko, EY; Park, YH; Cao, AY; Lin, CH; Toi, M; Wu, J; Lee, SC

BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

BREAST CANCER RES TR 2019 10.1007/s10549-019-05244-6

Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study

Lee¹, HM; Kim, BW; Park, S; Park, S; Lee, JE; Choi, YJ; Kim, SY; Woo, SU; Youn, HJ; Lee, I

Front Oncol 2019 10.3389/fonc.2019.00667

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Kwon¹, MJ; Lee, JE; Jeong, J; Woo, SU; Han, J; Kang, BI; Kim, JE; Moon, Y; Lee, SB; Lee, S; Choi, YL; Kwon, Y; Song, K; Gong, G; Shin, YK

MEDICINE 2019 10.1097/MD.0000000000015871

Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers Preliminary results for correlation with Oncotype DX recurrence scores

Nam¹, KJ; Park, H; Ko, ES; Lim, Y; Cho, HH; Lee, JE

BREAST CANCER RES TR 2019 10.1007/s10549-019-05157-4

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

Jung¹, J; Han, W; Lee, ES; Jung, SY; Han, JH; Noh, DY; Kim, Y; Choi, HJ; Lee, JE; Nam, SJ; Lee, JW; Kim, HJ; Um, E; Kim, JH; Park, S; Cho, YU

ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

CANCER RES TREAT 2019 10.4143/crt.2018.342

Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance

Kim¹, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH

ONCOLOGIST 2019 10.1634/theoncologist.2018-0184

Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study

Kang¹, D; Kim, IR; Choi, EK; Im, YH; Park, YH; Ahn, JS; Lee, JE; Nam, SJ; Lee, HK; Park, JH; Lee, DY; Lacouture, ME; Guallar, E; Cho, J

EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011

A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

PLoS One 2019 10.1371/journal.pone.0212309

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment

Kwon¹, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

ONCOL REP 2019 10.3892/or.2018.6910

TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4

Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Ryu¹, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

Hwang¹, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z

Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?

Lee¹, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ

NUTRIENTS 2019 10.3390/nu11010037

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients

Choi¹, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans

Kim¹, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

J BREAST CANC 2018 10.4048/jbc.2018.21.e54

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

Choi¹, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003

Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer

Bae¹, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ

J MED GENET 2018 10.1136/jmedgenet-2018-105565

Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort

Lee¹, JS; Oh, S; Park, SK; Lee, MH; Lee, JW; Kim, SW; Son, BH; Noh, DY; Lee, JE; Park, HL; Kim, MJ; Cho, SI; Lee, YK; Park, SS; Seong, MW

J BREAST CANC 2018 10.4048/jbc.2018.21.e50

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

Choi¹, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

ANALYST 2018 10.1039/c8an01752b

Formation of size-controllable tumour spheroids using a microfluidic pillar array (mu FPA) device

Lim¹, W; Hoang, HH; You, D; Han, J; Lee, JE; Kim, S; Park, S

BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y

Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer

Ryu¹, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

PLoS One 2018 10.1371/journal.pone.0207155

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer

Kwon¹, MJ; Lee, SB; Han, J; Lee, JE; Lee, JW; Gong, G; Beitsch, PD; Nem, SJ; Ahn, SH; Nam, BH; Shin, YK

PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004

Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.008

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

Kim¹, HJ; Lee, MH; Lee, JE; Park, S; Lee, ES; Kang, YJ; Shin, HN; Kim, SI; Lee, JH; Im, SA; Ahn, SH; Lee, KS; Sohn, J; Kim, S; Nam, SJ; Han, W

NAT GENET 2018 10.1038/s41588-018-0209-6

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Lee¹, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH

BREAST CANCER RES TR 2018 10.1007/s10549-018-4863-2

Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy

Lee¹, DY; Park, YH; Lee, JE; Choi, D

CLIN CANCER RES 2018 10.1158/1078-0432.CCR-17-3783

Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer

Park¹, H; Lim, Y; Ko, ES; Cho, HH; Lee, JE; Han, BK; Ko, EY; Choi, JS; Park, KW

BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

Kim¹, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010

Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment

Cho¹, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

ONCOLOGY-BASEL 2018 10.1159/000488944

Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype

Bae¹, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

RADIOLOGY 2018 10.1148/radiol.2018171987

Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection

Kim¹, GR; Choi, JS; Han, BK; Lee, JE; Nam, SJ; Ko, EY; Ko, ES; Lee, SK

J BREAST CANC 2018 10.4048/jbc.2018.21.2.222

Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer

Kim¹, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

J BREAST CANC 2018 10.4048/jbc.2018.21.2.173

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

J BREAST CANC 2018 10.4048/jbc.2018.21.2.206

Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?

Cho¹, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY

WORLD J SURG 2018 10.1007/s00268-017-4342-7

Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer

Park¹, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

EUR J CANCER PREV 2018 10.1097/CEJ.0000000000000353

Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study

Shin¹, J; Lee, JE; Ko, HY; Nguyen, TL; Nam, SJ; Hopper, JL; Song, YM

NAT COMMUN 2018 10.1038/s41467-018-04129-4

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Kan¹, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH

PLoS One 2018 10.1371/journal.pone.0195756

Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer

Nam¹, SY; Ko, ES; Lim, Y; Han, BK; Ko, EY; Choi, JS; Lee, JE

J BREAST CANC 2018 10.4048/jbc.2018.21.1.21

Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells

Jeong¹, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S

J BREAST CANC 2018 10.4048/jbc.2018.21.1.91

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy

Park¹, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH

TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

Kim¹, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE

CELL PHYSIOL BIOCHEM 2018 10.1159/000487171

Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells

Kim¹, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE

CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003

Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

Park¹, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

QUAL LIFE RES 2018 10.1007/s11136-017-1723-1

Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors

Yun¹, YH; Jung, JY; Sim, JA; Lee, J; Noh, DY; Han, W; Park, KJ; Jeong, SY; Park, JW; Wu, HG; Chie, EK; Kim, HJ; Jung, KH; Zo, JI; Kim, S; Lee, JE; Nam, SJ; Lee, ES; Oh, JH; Kim, YW; Kim, YT; Shim, YM

BMC CANCER 2018 10.1186/s12885-017-3965-2

A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors

Park¹, E; Yoon, J; Choi, EK; Kim, IR; Kang, D; Lee, SK; Lee, JE; Nam, SJ; Ahn, JS; Visser, A; Cho, J

GENOME RES 2018 10.1101/gr.223263.117

SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells

Han¹, KY; Kim, KT; Joung, JG; Son, DS; Kim, YJ; Jo, A; Jeon, HJ; Moon, HS; Yoo, CE; Chung, W; Eum, HH; Kim, S; Kim, HK; Lee, JE; Ahn, MJ; Lee, HO; Park, D; Park, WY

BMB REP 2017 10.5483/BMBRep.2017.50.12.096

Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells

You¹, D; Jung, SP; Jeong, Y; Bae, SY; Lee, JE; Kim, S

BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5

Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society

Ryu¹, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW

PSYCHO-ONCOL 2017 10.1002/pon.4408

Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor

Kang¹, D; Kim, IR; Choi, EK; Yoon, JH; Lee, SK; Lee, JE; Nam, SJ; Han, W; Noh, DY; Cho, J

ONCOTARGET 2017 10.18632/oncotarget.22220

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer

Woo¹, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY

NAT COMMUN 2017 10.1038/s41467-017-01470-y

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

Shin¹, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY

BREAST CANCER RES TR 2017 10.1007/s10549-017-4423-1

Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy

Kang¹, YJ; Han, W; Park, S; You, J; Yi, HW; Park, S; Nam, S; Kim, JH; Yun, KW; Kim, HJ; Ahn, SH; Park, S; Lee, JE; Lee, ES; Noh, DY; Lee, JW

CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014

Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis

Ryu¹, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ

ONCOTARGET 2017 10.18632/oncotarget.21198

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy

Kim¹, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH

J BREAST CANC 2017 10.4048/jbc.2017.20.3.297

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry

You¹, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE

J BREAST CANC 2017 10.4048/jbc.2017.203.270

Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy

Kim¹, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Kim¹, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

ONCOTARGET 2017 10.18632/oncotarget.10843

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction

Jeon¹, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE

BREAST CANCER RES TR 2017 10.1007/s10549-017-4234-4

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer

Han¹, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK

PSYCHIATRY INVESTIG 2017 10.4306/pi.2017.14.4.491

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study

Heo¹, JY; Yi, H; Fava, M; Mischoulon, D; Kim, K; Yoon, S; Jeon, HJ; Lee, JE

J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24.

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study

Ryu JM1¹, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.

J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24.

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy

Kim I1¹, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.

Sci Rep. 2017 Mar 28;7:45554. doi: 10.1038/srep45554.

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer

Gong G1¹, Kwon MJ2,3, Han J4, Lee HJ1, Lee SK5, Lee JE5, Lee SH6, Park S7, Choi JS7, Cho SY8, Ahn SH9, Lee JW9, Cho SR4, Moon Y4, Nam BH10, Nam SJ5, Choi YL8,11,12, Shin YK7,13,14.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746

Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy

Yoon N¹, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

Clin Breast Cancer. 2017 Feb;17(1):e19-e29. doi: 10.1016/j.clbc.2016.06.020. Epub 2016 Jul 9.

Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer

Park S1¹, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.

Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25.

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer

Kim H1¹, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.

Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746.

Conditional disease-free survival among patients with breast cancer

Paik HJ1¹, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.

Oncol Rep. 2016 Apr;35(4):2398-404. doi: 10.3892/or.2016.4557. Epub 2016 Jan 13.

MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells

Kim S1¹, Jeon M1, Lee JE1, Nam SJ1.

BMC Cancer. 2016 Feb 22;16:138. doi: 10.1186/s12885-016-2195-3.

Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Kim JY1¹, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.

Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30.

Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype

Alramadhan M1¹, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.

Chem Biol Interact. 2016 Oct 25;258:126-33. doi: 10.1016/j.cbi.2016.08.021. Epub 2016 Aug 25.

Elevated IL-1 beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone

Jeon M1¹, Han J2, Nam SJ2, Lee JE3, Kim S4.

PLoS One. 2016 Oct 31;11(10):e0165814. doi: 10.1371/journal.pone.0165814. eCollection 2016.

Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer

Hyun SH1¹, Ahn HK2, Lee JH1, Choi JY1, Kim BT1, Park YH3, Im YH3, Lee JE4, Nam SJ4, Lee KH1.

Cancer Res Treat. 2016 Oct;48(4):1382-1388. Epub 2016 Mar 11.

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea

Kim HK1¹, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.

Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2.

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Ryu JM1¹, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.

Oncotarget. 2016 Jan 12;7(2):1544-58. doi: 10.18632/oncotarget.6441.

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-beta 1 signaling pathway

Kim S1¹, Lee J1, Jeon M1,2, Lee JE1,2, Nam SJ1.

Oncol Rep. 2016 Sep;36(3):1717-22. doi: 10.3892/or.2016.4972. Epub 2016 Jul 25.

STC-1 expression is upregulated through an Akt/NF-B-dependent pathway in triple-negative breast cancer cells

Jeon M1¹, Han J1, Nam SJ1, Lee JE1, Kim S1.

J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23.

Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review

Seong M1¹, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.

PLoS One. 2016 Sep 20;11(9):e0163254. doi: 10.1371/journal.pone.0163254. eCollection 2016.

Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series

Lee MY1¹, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.

SCIENTIFIC REPORTS, AUG 22 2016, 6, DOI: 10.1038/srep31804

The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment

Kim JY¹, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH

World J Surg. 2016 Aug;40(8):2028-35. doi: 10.1007/s00268-016-3487-0.

Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm

Ryu JM1¹, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.

Tumour Biol. 2016 Aug;37(8):11397-407. doi: 10.1007/s13277-016-5000-7. Epub 2016 Mar 16.

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-beta 2 expression

Kim S1¹, Han J2, Jeon M2,3, You D2,3, Lee J2, Kim HJ2, Bae S2, Nam SJ2, Lee JE4,5.

Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19.

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer

Kim H1¹, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.

Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11.

Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3.

Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

Yoon N1¹, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24.

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes

Kim SW1¹, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.

Medicine (Baltimore). 2016 Apr;95(16):e3299. doi: 10.1097/MD.0000000000003299.

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer

Choi MY1¹, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.

Tumour Biol. 2016 Apr;37(4):4991-9. doi: 10.1007/s13277-015-4345-7. Epub 2015 Nov 4.

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells

Kim S1¹, Lee J2, Jeon M2,3, Lee JE2,3, Nam SJ4.

Oncotarget. 2015 Sep 15;6(27):24499-510.

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Park K1¹, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.

J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24.

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast

Park JS1¹, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.

Psychooncology. 2015 Dec;24(12):1723-30. doi: 10.1002/pon.3839. Epub 2015 May 26.

Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT)

Yun YH1¹,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.

Oncotarget. 2015 Dec 22;6(41):43731-42. doi: 10.18632/oncotarget.6192.

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer

Lee JY1¹, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.

J Breast Cancer. 2015 Dec;18(4):386-93. doi: 10.4048/jbc.2015.18.4.386. Epub 2015 Dec 23.

Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery

Lee JH1¹, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.

Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18.

Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Ann Surg Oncol. 2015 Oct;22(11):3481-8. doi: 10.1245/s10434-015-4399-1. Epub 2015 Feb 5.

The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women

Kim J1¹, Han W2, Jung SY3, Park YH4, Moon HG5, Ahn SK6, Lee JW7, Kim MK5, Kim JJ5, Lee ES5, You TK1, Kang HS3, Lee ES3, Ro J3, Lee JE4, Nam SJ4, Yim YH4, Park IA5, Noh DY5.

Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24.

Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients

Park JS1¹, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.

Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13.

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.

Oncol Rep. 2015 Sep;34(3):1613-9. doi: 10.3892/or.2015.4116. Epub 2015 Jul 8.

Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells

Kim S1¹, Lee J1, Oh SJ1, Nam SJ1, Lee JE1.

Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9.

Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation

Kim H1¹, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.

Eur J Cancer Prev. 2015 Sep;24(5):422-9. doi: 10.1097/CEJ.0000000000000099.

Mammographic density and risk of breast cancer in Korean women

Kim BK1¹, Choi YH, Nguyen TL, Nam SJ, Lee JE, Hopper JL, Sung J, Song YM.

Cytokine. 2015 Sep;75(1):151-8. doi: 10.1016/j.cyto.2015.05.020. Epub 2015 Jun 15.

Elevated TGF-beta 1 and -beta 2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells

Kim S1¹, Lee J2, Jeon M3, Nam SJ2, Lee JE4.

Breast Cancer Res Treat. 2015 Aug;152(3):675-82. doi: 10.1007/s10549-015-3502-4. Epub 2015 Jul 22.

Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study

Kang D1¹, Kim IR, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Park H, Kim E, Lee HK, Lee DY, Cho J.

PLoS One. 2015 Aug 4;10(8):e0124658. doi: 10.1371/journal.pone.0124658. eCollection 2015.

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival

Lee SK1¹, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.

Breast. 2015 Jun;24(3):213-7. doi: 10.1016/j.breast.2015.01.012. Epub 2015 Feb 24.

Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea

Park YH1¹, Lee SJ1, Jung HA1, Kim SM1, Kim MJ1, Kil WH2, Lee JE2, Nam SJ2, Ahn JS1, Im YH3.

Aesthetic Plast Surg. 2015 Jun;39(3):369-76. doi: 10.1007/s00266-015-0493-9. Epub 2015 Apr 30.

Preoperative Magnetic Resonance Imaging-Based Breast Volumetry for Immediate Breast Reconstruction

Kim H1¹, Mun GH, Wiraatmadja ES, Lim SY, Pyon JK, Oh KS, Lee JE, Nam SJ, Bang SI.

Microsurgery. 2015 May;35(4):272-8. doi: 10.1002/micr.22328. Epub 2014 Sep 16.

Is Holm Zone III safe from fat necrosis in medial row perforator-based deep inferior epigastric perforator flaps

Lee KT1¹, Lee JE2, Nam SJ2, Han BK3, Mun GH1.

Breast Cancer Res Treat. 2015 May;151(1):157-68. doi: 10.1007/s10549-015-3377-4. Epub 2015 Apr 12.

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study

Kang E1¹, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group.

Oncology. 2015;88(6):337-44. doi: 10.1159/000368985. Epub 2015 Feb 25.

Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer

Lee SK1¹, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.

ANZ J Surg. 2015 Apr;85(4):240-4.

Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone

Rhu J¹, Lee SK, Kil WH, Lee JE, Nam SJ.

Cancer Res Treat. 2015 Apr;47(2):208-14. doi: 10.4143/crt.2013.223. Epub 2014 Sep 11.

The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea

Lee MH1¹, Han W2, Lee JE3, Kim KS4, Park H5, Kim J2, Bae SY3, Shin HJ4, Lee JW5, Lee ES1.

Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24.

A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery

Park YH1¹, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

Exp Cell Res. 2015 Apr 10;333(1):116-26. doi: 10.1016/j.yexcr.2015.02.019. Epub 2015 Mar 3.

Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells

Jeon M1¹, Lee J2, Nam SJ2, Shin I3, Lee JE4, Kim S5.

Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11.

Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer

Hyun SH1¹, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.

BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4.

Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer

Bae SY1¹, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.

Surgery. 2015 Mar;157(3):518-25. doi: 10.1016/j.surg.2014.10.013. Epub 2014 Nov 6.

Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study

Lee SK1¹, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.

J Breast Cancer. 2015 Mar;18(1):22-8. doi: 10.4048/jbc.2015.18.1.22. Epub 2015 Mar 27.

Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis

Kim JY1¹, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.

J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27.

Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer

Yu JI1¹, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.

Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19.

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology

Jung HA1¹, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

J Breast Cancer. 2014 Sep;17(3):244-9. doi: 10.4048/jbc.2014.17.3.244. Epub 2014 Sep 30.

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy

Kil WH1¹, Lee JE1, Nam SJ1.

J Breast Cancer. 2014 Sep;17(3):279-86. doi: 10.4048/jbc.2014.17.3.279. Epub 2014 Sep 30.

Breast Cancer Screening Knowledge and Perceived Health Beliefs among Immigrant Women in Korea

Kim J1¹, Lee SK2, Lee J3, Choi MY3, Jung SP4, Kim MK2, Kim S2, Nam SJ2, Lee JE2, Kil WH2.

Cancer Chemother Pharmacol. 2014 Sep;74(3):521-9. doi: 10.1007/s00280-014-2542-5. Epub 2014 Jul 22.

Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer

Choi MK1¹, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4.

Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers

Park YH1¹, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.

Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24.

Aberrant DNA methylation of integrin alpha 4 in human breast cancer

Do SI1¹, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.

J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1.

Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection

Noh JM1¹, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.

World J Surg. 2014 May;38(5):1065-9. doi: 10.1007/s00268-014-2468-4.

The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer

Lee SK1¹, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.

Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12.

Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population

Noh JM1¹, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.

Oncol Rep. 2014 Mar;31(3):1423-8. doi: 10.3892/or.2013.2936. Epub 2013 Dec 19.

Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells

Kim S1¹, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.

Ann Oncol. 2014 Feb;25(2):346-51. doi: 10.1093/annonc/mdt476. Epub 2013 Dec 29.

Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients

Cho J1¹, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ.

Oncol Rep. 2014 Dec;32(6):2666-72. doi: 10.3892/or.2014.3514. Epub 2014 Sep 24.

Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells

Kim S1¹, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.

Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.

Invasive Paget disease of the breast: 20 years of experience at a single institution

Lee HW1¹, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

Phytother Res. 2014 Nov;28(11):1654-60. doi: 10.1002/ptr.5178. Epub 2014 May 30.

Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells

Han J1¹, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.

Asian Pac J Cancer Prev. 2014;15(20):8607-12.

Association between Socioeconomic Status and Altered Appearance Distress, Body Image, and Quality of Life Among Breast Cancer Patients

Chang O1¹, Choi EK, Kim IR, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Cho J.

Oncol Rep. 2014 Nov;32(5):2230-6. doi: 10.3892/or.2014.3450. Epub 2014 Aug 29.

Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells

Kim S1¹, Jeon M1, Lee J1, Han J1, Oh SJ1, Jung T1, Nam SJ1, Kil WH1, Lee JE1.

Psychooncology. 2014 Oct;23(10):1103-10. doi: 10.1002/pon.3531. Epub 2014 Mar 24.

Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients

Choi EK1¹, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J.

Breast. 2014 Oct;23(5):670-5. doi: 10.1016/j.breast.2014.07.005. Epub 2014 Jul 31.

Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy

Kim J1¹, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.

Ann Surg Treat Res. 2014 Oct;87(4):167-73. doi: 10.4174/astr.2014.87.4.167. Epub 2014 Sep 25.

Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells

Kil WH1¹, Kim SM1, Lee JE1, Park KS2, Nam SJ1.

Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23.

Excision alone for small size ductal carcinoma in situ of the breast

Kim H1¹, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.

Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19.

Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations

Park H1¹, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.

Oncol Lett. 2014 Aug;8(2):507-512. Epub 2014 May 30.

Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines

Kim SH1¹, Lee HY2, Jung SP2, Kim S3, Lee JE3, Nam SJ3, Bae JW2.

Breast Cancer Res Treat. 2014 Jul;146(1):63-9. doi: 10.1007/s10549-014-3006-7. Epub 2014 Jun 4.

A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients

Seong MW1¹, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Lee JE, Noh DY, Son BH, Park HL, Cho SI, Park SS; Korean Hereditary Breast Cancer Study Group, Kim SW.

J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.

Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

Lee JH1¹, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

Cancer Res Treat. 2014 Jan;46(1):104-7. doi: 10.4143/crt.2014.46.1.104. Epub 2014 Jan 15.

Primary Follicular Lymphoma in a Male Breast: A Case Report

Jung SP1¹, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.

Cell Physiol Biochem. 2013;32(5):1541-50. doi: 10.1159/000356591. Epub 2013 Nov 29.

Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells

Kim S1¹, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.

J Breast Cancer. 2013 Dec;16(4):417-25. doi: 10.4048/jbc.2013.16.4.417. Epub 2013 Dec 31.

Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma

Park I1¹, Kim J1, Kim M1, Bae SY1, Lee SK1, Kil WH1, Lee JE1, Nam SJ1.

Ann Surg Oncol. 2013 Oct;20(10):3341-7. doi: 10.1245/s10434-013-3175-3. Epub 2013 Aug 22.

Round Block Technique Without Cerclage in Breast-Conserving Surgery

Kim MK1¹, Kim J, Jung SP, Bae SY, Choi MY, Lee SK, Kim S, Kil WH, Kim SW, Kim JH, Kim JS, Nam SJ, Lee JE.

J Breast Cancer. 2013 Sep;16(3):345-8. doi: 10.4048/jbc.2013.16.3.345. Epub 2013 Sep 30.

Breast Metastasis from Rhabdomyosarcoma of the Anus in an Adolescent Female

Jung SP1¹, Lee Y, Han KM, Lee SK, Kim S, Bae SY, Kim J, Kim M, Kim S, Kil WH, Koo HH, Nam SJ, Bae JW, Lee JE.

J Korean Surg Soc. 2013 Jul;85(1):1-6. doi: 10.4174/jkss.2013.85.1.1. Epub 2013 Jun 26.

Experience of treatment of patients with granulomatous lobular mastitis

Hur SM1¹, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.

Breast Cancer Res Treat. 2013 Jun;139(3):741-50. doi: 10.1007/s10549-013-2570-6. Epub 2013 May 31.

HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients

Bae SY1¹, La Choi Y, Kim S, Kim M, Kim J, Jung SP, Choi MY, Lee SK, Kil WH, Lee JE, Nam SJ.

J Korean Surg Soc. 2013 May;84(5):273-80. doi: 10.4174/jkss.2013.84.5.273. Epub 2013 Apr 24.

Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer

Cho DH1¹, Lee SK, Kim S, Choi MY, Jung SP, Lee J, Kim J, Koo MY, Bae SY, Kim JH, Kim JS, Ho KW, Lee JE, Nam SJ, Yang JH.

J Korean Surg Soc. 2013 May;84(5):267-72. doi: 10.4174/jkss.2013.84.5.267. Epub 2013 Apr 24.

Primary breast lymphoma: a single institution's experience

Jung SP1¹, Kim M, Han KM, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

J Breast Cancer. 2013 Mar;16(1):97-103. doi: 10.4048/jbc.2013.16.1.97. Epub 2013 Mar 31.

Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients

Jung SP1¹, Hur SM, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim MK, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

Fam Cancer. 2013 Mar;12(1):75-81. doi: 10.1007/s10689-012-9578-7.

The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study

Han SA1¹, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.

J Breast Cancer. 2012 Sep;15(3):296-305. doi: 10.4048/jbc.2012.15.3.296. Epub 2012 Sep 28.

Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma

Jung SP1¹, Lee JE, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ.

J Breast Cancer. 2012 Sep;15(3):359-63. doi: 10.4048/jbc.2012.15.3.359. Epub 2012 Sep 28.

Occult Breast Cancers Manifesting as Axillary Lymph Node Metastasis in Men: A Two-Case Report

Hur SM1¹, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE, Yang JH.

J Breast Cancer. 2012 Sep;15(3):313-9. doi: 10.4048/jbc.2012.15.3.313. Epub 2012 Sep 28.

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma

Jung SP1¹, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim M, Kil WH, Cho EY, Choe JH, Kim JH, Kim JS, Nam SJ, Lee JE.

Breast Cancer Res Treat. 2012 Aug;134(3):1189-97. doi: 10.1007/s10549-012-2022-8. Epub 2012 Mar 22.

Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients

Kang E1¹, Park SK, Yang JJ, Park B, Lee MH, Lee JW, Suh YJ, Lee JE, Kim HA, Oh SJ, Kim SW; Korean Breast Cancer Society.

Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054.

A functional comparison between the HER2(high)/HER3 and the HER2l(ow/)HER3 dimers on heregulin-beta 1-induced MMP-1 and MMP-9 expression in breast cancer cells

Kim S1¹, Han J, Shin I, Kil WH, Lee JE, Nam SJ.

Ann Surg Oncol. 2012 Aug;19(8):2612-7. doi: 10.1245/s10434-012-2307-5. Epub 2012 Apr 4.

Clinicopathologic Risk Factors for the Local Recurrence of Phyllodes Tumors of the Breast

Jang JH1¹, Choi MY, Lee SK, Kim S, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Cho EY, Lee JE, Nam SJ, Yang JH.

J Surg Res. 2012 Jul;176(1):e21-9. doi: 10.1016/j.jss.2011.11.1041. Epub 2011 Dec 30.

Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-alpha in Breast Cancer Cells

Kim S1¹, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.

J Breast Cancer. 2012 Jun;15(2):230-8. doi: 10.4048/jbc.2012.15.2.230. Epub 2012 Jun 28.

Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine

Kim W1¹, Kim KS, Lee JE, Noh DY, Kim SW, Jung YS, Park MY, Park RW.

Breast Cancer Res Treat. 2012 Jun;133(3):1143-52. doi: 10.1007/s10549-012-2001-0. Epub 2012 Mar 2.

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

Son BH1¹, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society.

Asian Pac J Cancer Prev. 2012;13(4):1383-8.

Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study

Kim IR1¹, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, Nam SJ, Yang JH.

J Hum Genet. 2012 Mar;57(3):212-5. doi: 10.1038/jhg.2011.139. Epub 2012 Jan 5.

Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing

Jang JH1¹, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, Yang JH.

PLoS One. 2012;7(3):e33238. doi: 10.1371/journal.pone.0033238. Epub 2012 Mar 29.

Efficacy of an Educational Material on Second Primary Cancer Screening Practice for Cancer Survivors: A Randomized Controlled Trial

Shin DW1¹, Cho J, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Guallar E, Lee WC.

Oncol Rep. 2012 Feb;27(2):517-22. doi: 10.3892/or.2011.1511. Epub 2011 Oct 20.

TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells

Han J1¹, Kim S, Yang JH, Nam SJ, Lee JE.

Breast Cancer Res Treat. 2012 Jan;131(2):527-40. doi: 10.1007/s10549-011-1836-0. Epub 2011 Oct 30.

Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes

Kim J1¹, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Oncol Rep. 2012 Jan;27(1):210-5. doi: 10.3892/or.2011.1480. Epub 2011 Sep 29.

Effect of berberine on p53 expression by TPA in breast cancer cells

Kim S1¹, Han J, Kim NY, Lee SK, Cho DH, Choi MY, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE.

Cancer Lett. 2012 Jan 28;314(2):147-54. doi: 10.1016/j.canlet.2011.09.024. Epub 2011 Sep 29.

Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells

Kim S1¹, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

J Breast Cancer. 2011 Dec;14(4):308-13. doi: 10.4048/jbc.2011.14.4.308. Epub 2011 Dec 27.

Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis

Bae SY1¹, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.

J Breast Cancer. 2011 Dec;14(4):322-7. doi: 10.4048/jbc.2011.14.4.322. Epub 2011 Dec 27.

Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy

Lee J1¹, Lee SK, Kim S, Koo MY, Choi MY, Bae SY, Cho DH, Kim J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.

Surg Today. 2011 Dec;41(12):1665-9. doi: 10.1007/s00595-011-4503-5. Epub 2011 Oct 4.

Ileal Metastasis of Breast Cancer in a Patient with a BRCA2 Gene Mutation: Report of a Case

Cho DH1¹, Jeon YS, Choi MY, Lee SK, Kim SM, Hur SM, Koo MY, Bae SY, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.

Anticancer Res. 2011 Nov;31(11):3767-73.

Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells

Kim S1¹, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

World J Surg. 2011 Nov;35(11):2417-21. doi: 10.1007/s00268-011-1225-1.

Large Clinical Experience of Primary Angiosarcoma of the Breast in a Single Korean Medical Institute

Bae SY1¹, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.

J Breast Cancer. 2011 Sep;14(3):251-2. doi: 10.4048/jbc.2011.14.3.251. Epub 2011 Sep 29.

Invited Commentary on: Can CD44+/CD24-Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy

Lee JE1¹, Nam SJ.

Yonsei Med J. 2011 Sep;52(5):803-8. doi: 10.3349/ymj.2011.52.5.803.

Results from Over One Year of Follow-Up for Absorbable Mesh Insertion in Partial Mastectomy

Koo MY1¹, Lee SK, Hur SM, Bae SY, Choi MY, Cho DH, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Cancer. 2011 Aug 15;117(16):3850-9. doi: 10.1002/cncr.25951. Epub 2011 Feb 11.

Knowledge, Attitudes, Risk Perception, and Cancer Screening Behaviors Among Cancer Survivors

Shin DW1¹, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Lee WC, Guallar E, Cho J.

J Breast Cancer. 2011 Jun;14(2):165-6. doi: 10.4048/jbc.2011.14.2.165. Epub 2011 Jun 18.

Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic

Lee JE1¹, Yang JH, Nam SJ.

Breast Cancer Res Treat. 2011 Apr;126(2):471-8. doi: 10.1007/s10549-011-1359-8. Epub 2011 Feb 2.

The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients

Bae SY1¹, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Kim S, Choe JH, Lee JE, Kim JH, Kim JS, Nam SJ, Yang JH.

World J Surg. 2011 Mar;35(3):573-9. doi: 10.1007/s00268-010-0942-1.

Cases and Literature Review of Breast Sparganosis

Koo M1¹, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

J Breast Cancer. 2011 Mar;14(1):33-8. doi: 10.4048/jbc.2011.14.1.33. Epub 2011 Mar 31.

The 70-Gene Prognostic Signature for Korean Breast Cancer Patients

Na KY1¹, Kim KS, Lee JE, Kim HJ, Yang JH, Ahn SH, Moon BI, Kim RM, Ko SM, Jung YS.

Survey of Psychosocial Problems Facing Breast Cancer Survivors after Undergoing a Mastectomy and Their Awareness of Breast Reconstruction

The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study

Phytomedicine. 2010 Dec 1;17(14):1127-32. doi: 10.1016/j.phymed.2010.03.013.

12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells

Kim S1¹, Lee HS, Lee SK, Kim SH, Hur SM, Kim JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE, Nam SJ.

Pharmacology. 2010;86(5-6):313-9. doi: 10.1159/000321327. Epub 2010 Nov 11.

Pifithrin-alpha an Inhibitor of p53 Transactivation, Up-Regulates COX-2 Expression through an MAPK-Dependent Pathway

Kim S1¹, Han J, Lee SK, Hur SM, Koo M, Cho DH, Bae SY, Choi MY, Shin I, Yang JH, Nam SJ, Lee JE.

Single-Port Access Laparoscopic Prophylactic Bilateral Salpingo-Oophorectomy in BRCA-Positive Breast Cancer Patient: A Case Report

Secondary Partial Mastectomy with Contralateral Sentinel Lymph Node Biopsy for Ipsilateral Breast Cancer Recurrence after Conservative Surgery: Report of 2 Cases

Incidental Detection of Ductal Carcinoma In Situ of the Breast from Bilateral Prophylactic Mastectomy of Asymptomatic BRCA2 Mutation Carrier: A Case Report

Biopsychosocial Predictors of the Quality of Life in Breast Cancer Patients

The Preoperative Role of Breast-specific Gamma Imaging for the Breast Cancer Patients: In Comparison with Conventional Imaging Modality

Characteristics of Invasive Micropapillary Carcinoma of the Breast: In Comparison with Invasive Ductal Carcinoma

Intracystic Papillary Carcinoma in the Male Breast

J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453.

Characteristics of Metastasis in the Breast From Extramammary Malignancies

Lee SK1¹, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Implications of Isolated Tumor Cells in Sentinel Lymph Nodes of Breast Cancer Patients

Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System

Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea

Molecules. 2009 Oct 26;14(11):4300-11. doi: 10.3390/molecules14114300.

Silibinin Suppresses TNF-alpha-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway

Kim S1¹, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, Hur SM, Kim JH, Choe JH, Nam SJ, Yang JH, Kim S, Lee JE, Kim JS.

J Ethnopharmacol. 2009 Nov 12;126(2):252-7. doi: 10.1016/j.jep.2009.08.032. Epub 2009 Aug 26.

Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells

Kim S1¹, Kim SH, Hur SM, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.

Phytomedicine. 2009 Jun;16(6-7):573-80. doi: 10.1016/j.phymed.2008.11.006. Epub 2009 Jan 31.

Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells

Kim S1¹, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

Cell Signal. 2009 Jun;21(6):892-8.

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

Kim S1¹, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.

The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report

Breast J. 2013 Jul-Aug;19(4):388-93. doi: 10.1111/tbj.12122. Epub 2013 May 31.

The Impact of the Ratio of Positive Nodes to Removed Nodes on Recurrence and Overall Survival in Node Positive Breast Cancer Patients

Martin FT1¹, O'Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ.

Molecules. 2008 Dec 3;13(12):2975-85. doi: 10.3390/molecules13122975.

Berberine Suppresses TNF-alpha-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells

Kim S1¹, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE.

J Breast Cancer. 2011 Jun;14(2):165-6. doi: 10.4048/jbc.2011.14.2.165. Epub 2011 Jun 18.

Breast cancer stem cells: Changing therapeutic paradigm

Lee JE1¹, Yang JH, Nam SJ.

Yonsei Med J. 2007 Jun 30;48(3):465-73.

Analysis of prognostic factors and treatment modality changes in breast cancer: A single institution study in Korea

Lee WS1¹, Lee JE, Kim JH, Nam SJ, Yang JH.